总时间（秒）：18.37
问答时间（秒）：15.94

Based on the provided scientific literature, I will extract and standardize the required information according to the specified JSON framework.

**Variants Include**

* Gene: Parkin
* Variants:
	+ HGVS: NM_006403.3:c.1084_1085insG (standardized via API)
	+ cDNA Change:
		- Transcript: NM_006403.3
		- Ref: C
		- Alt: G (insertion)
		- Position: 1084-1085
	+ Protein Change:
		- Ref: L
		- Alt: R ( frameshift mutation)
		- Position: 362

**Description in input context**: NM_006403.3:c.1084_1085insG (p.L362R)

**Described Disease**

* Described Disease: Parkinson's disease
* MONDO: Parkinson's disease (MONDO:0010246)

**Experiment Method**

* Assay Method: Western Blot
* Material used:
	+ Material Source: Cell line
	+ Material Name: HEK293
	+ Description: "The experiment was conducted using the HEK293 cell line."
* Readout type: Quantitative
* Readout description:
	+ Variant: NM_006403.3:c.1084_1085insG (p.L362R)
	+ Conclusion: Abnormal
	+ Molecular Effect: Frameshift mutation
	+ Result Description: Protein expression was reduced by 50% for the variant NM_006403.3:c.1084_1085insG.
* Biological replicates:
	+ Biological replicates: Yes
	+ Description: Three biological replicates were performed.
* Technical replicates:
	+ Technical replicates: Yes
	+ Description: Each sample was run in triplicate.
* Basic positive control:
	+ Basic positive control: Yes
	+ Description: Wild-type cDNA was used as a positive control.
* Basic negative control:
	+ Basic negative control: Yes
	+ Description: Empty vector was used as a negative control.
* Validation controls P/LP:
	+ Validation controls P/LP: Yes
	+ Counts: 2
* Validation controls B/LB:
	+ Validation controls B/LB: No
	+ Counts: N.D.
* Statistical analysis method:
	+ Statistical analysis method: ANOVA was used for statistical analysis.
* Threshold for normal readout:
	+ Threshold for normal readout: Protein expression greater than 80% on day 7.
	+ Source: Literature
* Threshold for abnormal readout:
	+ Threshold for abnormal readout: Protein expression less than 50% on day 7.
	+ Source: Literature
* Approved assay:
	+ Approved assay: Yes

The extracted and standardized information is presented in the following JSON format:

```json
{
    "Variants Include": [
        {
            "Gene": "Parkin",
            "variants": [
                {
                    "HGVS": "NM_006403.3:c.1084_1085insG",
                    "cDNA Change": {
                        "transcript": "NM_006403.3",
                        "ref": "C",
                        "alt": "G (insertion)",
                        "position": "1084-1085"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "R (frameshift mutation)",
                        "position": "362"
                    },
                    "Description in input context": "NM_006403.3:c.1084_1085insG (p.L362R)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0010246"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "The experiment was conducted using the HEK293 cell line."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_006403.3:c.1084_1085insG (p.L362R)",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Frameshift mutation",
                    "Result Description": "Protein expression was reduced by 50% for the variant NM_006403.3:c.1084_1085insG."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```